JP2021046360A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021046360A5 JP2021046360A5 JP2019168668A JP2019168668A JP2021046360A5 JP 2021046360 A5 JP2021046360 A5 JP 2021046360A5 JP 2019168668 A JP2019168668 A JP 2019168668A JP 2019168668 A JP2019168668 A JP 2019168668A JP 2021046360 A5 JP2021046360 A5 JP 2021046360A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- group
- gene product
- hydrogen atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 11
- 108090000623 proteins and genes Proteins 0.000 claims 11
- 239000008194 pharmaceutical composition Substances 0.000 claims 10
- 206010028980 Neoplasm Diseases 0.000 claims 9
- 241000700605 Viruses Species 0.000 claims 9
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 7
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 7
- 125000005843 halogen group Chemical group 0.000 claims 7
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 6
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 6
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 5
- 125000001072 heteroaryl group Chemical group 0.000 claims 4
- 230000008685 targeting Effects 0.000 claims 4
- 125000003118 aryl group Chemical group 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 241000711549 Hepacivirus C Species 0.000 claims 2
- 241001502974 Human gammaherpesvirus 8 Species 0.000 claims 2
- 241000701806 Human papillomavirus Species 0.000 claims 2
- 206010025323 Lymphomas Diseases 0.000 claims 2
- 241000579048 Merkel cell polyomavirus Species 0.000 claims 2
- 125000003277 amino group Chemical group 0.000 claims 2
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 claims 2
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 125000003107 substituted aryl group Chemical group 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 125000004434 sulfur atom Chemical group 0.000 claims 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 1
- 208000009746 Adult T-Cell Leukemia-Lymphoma Diseases 0.000 claims 1
- 208000016683 Adult T-cell leukemia/lymphoma Diseases 0.000 claims 1
- 206010008263 Cervical dysplasia Diseases 0.000 claims 1
- 206010008342 Cervix carcinoma Diseases 0.000 claims 1
- 241000700721 Hepatitis B virus Species 0.000 claims 1
- 208000007766 Kaposi sarcoma Diseases 0.000 claims 1
- 208000028018 Lymphocytic leukaemia Diseases 0.000 claims 1
- 208000002030 Merkel cell carcinoma Diseases 0.000 claims 1
- 206010029266 Neuroendocrine carcinoma of the skin Diseases 0.000 claims 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 201000006966 adult T-cell leukemia Diseases 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 201000010881 cervical cancer Diseases 0.000 claims 1
- 208000017763 cutaneous neuroendocrine carcinoma Diseases 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 claims 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 208000003747 lymphoid leukemia Diseases 0.000 claims 1
- 230000002101 lytic effect Effects 0.000 claims 1
- 208000020668 oropharyngeal carcinoma Diseases 0.000 claims 1
- 201000006958 oropharynx cancer Diseases 0.000 claims 1
- 125000004430 oxygen atom Chemical group O* 0.000 claims 1
- 208000012498 virus associated tumor Diseases 0.000 claims 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019168668A JP7397467B2 (ja) | 2019-09-17 | 2019-09-17 | 腫瘍抑制剤 |
| US17/024,435 US12138253B2 (en) | 2019-09-17 | 2020-09-17 | Tumor suppression |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019168668A JP7397467B2 (ja) | 2019-09-17 | 2019-09-17 | 腫瘍抑制剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021046360A JP2021046360A (ja) | 2021-03-25 |
| JP2021046360A5 true JP2021046360A5 (https=) | 2022-09-13 |
| JP7397467B2 JP7397467B2 (ja) | 2023-12-13 |
Family
ID=74877763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019168668A Active JP7397467B2 (ja) | 2019-09-17 | 2019-09-17 | 腫瘍抑制剤 |
Country Status (2)
| Country | Link |
|---|---|
| US (1) | US12138253B2 (https=) |
| JP (1) | JP7397467B2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4159214B1 (en) * | 2020-06-02 | 2026-03-04 | KinoPharma, Inc. | Composition for treating, improving, and/or preventing progression of bovine papillomatosis caused by bovine papillomavirus |
| CN119497616A (zh) * | 2022-05-02 | 2025-02-21 | 株式会社基诺制药 | 含有苯胺衍生物的皮肤用外用剂 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2801848C (en) | 2003-12-26 | 2015-03-31 | Masatoshi Hagiwara | Methods for controlling sr protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control sr protein activity |
| WO2009020198A1 (ja) | 2007-08-03 | 2009-02-12 | Kinopharma, Inc. | 抗ｄｎａウイルス作用を有するアニリン誘導体 |
| CN105164127A (zh) * | 2013-03-11 | 2015-12-16 | 艾伯维公司 | 溴结构域抑制剂 |
| JP6919891B2 (ja) | 2017-08-23 | 2021-08-18 | 国立大学法人島根大学 | Ｅｐｓｔｅｉｎ−Ｂａｒｒウイルス関連癌に特異的な抗腫瘍剤 |
-
2019
- 2019-09-17 JP JP2019168668A patent/JP7397467B2/ja active Active
-
2020
- 2020-09-17 US US17/024,435 patent/US12138253B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2007116119A (ru) | Производные циклоспорина, замещенные 3-эфиром и 3-тиоэфиром, для лечения и профилактики инфекционного гепатита с | |
| JP2019500387A5 (https=) | ||
| JP2013056886A5 (https=) | ||
| JP2005523922A5 (https=) | ||
| CA2490200A1 (en) | 2' and 3'-nucleoside prodrugs for treating flaviviridae infections | |
| JP2009537550A5 (https=) | ||
| JP2009531403A5 (https=) | ||
| NZ610715A (en) | Antiviral compounds and methods | |
| JP2013523765A5 (https=) | ||
| JP2005505499A5 (https=) | ||
| JP2005526857A5 (https=) | ||
| JP2005533040A5 (https=) | ||
| JP2010501584A5 (https=) | ||
| JP2012519691A5 (https=) | ||
| US6248782B1 (en) | Method of treating viral diseases | |
| JP2005508962A5 (https=) | ||
| WO2017114812A1 (en) | Combination therapy of an hbsag inhibitor and an interferon | |
| JP2019511542A5 (https=) | ||
| JP2021046360A5 (https=) | ||
| JP2014532716A5 (https=) | ||
| JP2018520147A5 (https=) | ||
| CN114787165A (zh) | 大环tlr7激动剂、其制备方法、药物组合物及其用途 | |
| JP2024112835A5 (https=) | ||
| JP2005511535A5 (https=) | ||
| JP2008502694A (ja) | ボリン酸錯体の抗ウイルス使用 |